| Literature DB >> 32868838 |
M Fikere1,2,3, D M Barbulescu4, M M Malmberg1,2, G C Spangenberg1,2, N O I Cogan1,2, H D Daetwyler5,6.
Abstract
Blackleg disease causes yield losses in canola (Brassica napus L.). To identify resistance genes and genomic regions, genome-wide association studies (GWAS) of 585 diverse winter and spring canola accessions were performed using imputed whole-genome sequence (WGS) and transcriptome genotype-by-sequencing (GBSt). Blackleg disease phenotypes were collected across three years in six trials. GWAS were performed in several ways and their respective power was judged by the number of significant single nucleotide polymorphisms (SNP), the false discovery rate (FDR), and the percentage of SNP that validated in additional field trials in two subsequent years. WGS GWAS with 1,234,708 million SNP detected a larger number of significant SNP, achieved a lower FDR and a higher validation rate than GBSt with 64,072 SNP. A meta-analysis combining survival and average internal infection resulted in lower FDR but also lower validation rates. The meta-analysis GWAS identified 79 genomic regions (674 SNP) conferring potential resistance to L. maculans. While several GWAS signals localised in regions of known Rlm genes, fifty-three new potential resistance regions were detected. Seventeen regions had underlying genes with putative functions related to disease defence or stress response in Arabidopsis thaliana. This study provides insight into the genetic architecture and potential molecular mechanisms underlying canola L. maculans resistance.Entities:
Mesh:
Year: 2020 PMID: 32868838 PMCID: PMC7459325 DOI: 10.1038/s41598-020-71274-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Phenotypic summary after spatial adjustment of the three traits in the association panel across environments during 2015–2017 growing seasons for 585 winter and spring lines in 2015, and 168 spring lines grown in 2016 and 2017.
| Year | Locations | Trait | Mean | SD | |
|---|---|---|---|---|---|
| 2015 | WL15 | Emergence count | 31.24 | 11.13 | 0.46 |
| Survival rate | 22.5 | 16.96 | 0.80 | ||
| AvInf | 84.1 | 12.54 | 0.77 | ||
| GL15 | Emergence count | 14.44 | 3.49 | 0.42 | |
| Survival rate | 56.03 | 15.05 | 0.54 | ||
| AvInf | 57.04 | 16.9 | 0.74 | ||
| 2016 | MI16 | Emergence score | 5.24 | 0.31 | 0.38 |
| AvInf | 19.2 | 4.39 | 0.76 | ||
| HrI16 | Emergence score | 6.41 | 0.56 | 0.44 | |
| AvInf | 7.22 | 4.44 | 0.68 | ||
| 2017 | Hr17 | Emergence score | 5.37 | 1.12 | 0.45 |
| AvInf | 11.36 | 3.18 | 0.67 | ||
| HrI17 | Emergence score | 4.35 | 0.3 | 0.42 | |
| AvInf | 17.48 | 5.56 | 0.72 |
AvInf = Average internal infection, WL15 = Wickliffe, GL15 = Green Lake, MI16 = Mininera, HrI16 = Horsham irrigated 2016, HrI17 = Horsham irrigated 2017, Hr17 = Horsham rain-fed 2017 and = broad sense heritability.
Figure 1Heat map of the genomic relationship matrix for 585 diverse canola lines using the imputed 1,234,708 SNP markers. Mixed = spring canola lines with winter background; darker colour indicates greater relatedness. Figure produced in R3.6.
Comparison of GBSt versus WGS GWAS as well as two alternative ways to code genotypes (dosage and hardcoded) for emergence (EME), average internal infection (AvInf), and survival (Surv) at Wickliffe (WL) and Green Lake (GL) sites in 2015, where FDR is the false discovery rate.
| Single trait GWAS using GBSt dosage genotypes | Single trait GWAS using WGS dosage genotypes | Single trait GWAS using WGS in 012 genotypes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of sig. SNPs and FDR at 4 p-values | No. of sig. SNPs and FDR at 4 p-values | No. of sig. SNPs and FDR at 4 p-values | ||||||||||
| p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | |
| EMEWL | 437 | 31 | 11 | 0 | 5,942 | 1,396 | 269 | 4 | 5,525 | 787 | 104 | 3 |
| FDR(%) | 14.7 | 20.7 | 5.8 | – | 20.8 | 8.8 | 4.6 | 40.2 | 22.4 | 15.7 | 11.9 | 41.2 |
| SurvWL | 586 | 27 | 14 | 1 | 5,719 | 1,197 | 101 | 3 | 6,807 | 895 | 93 | 2 |
| FDR(%) | 10.9 | 23.7 | 4.6 | 6.4 | 21.6 | 10.3 | 12.2 | 41.2 | 18.1 | 13.8 | 12.1 | 61.7 |
| AvInfWL | 639 | 32 | 18 | 1 | 4,895 | 1,106 | 287 | 3 | 4,936 | 889 | 97 | 1 |
| FDR(%) | 10.1 | 20.1 | 3.6 | 6.4 | 25.2 | 11.2 | 4.3 | 41.2 | 25.1 | 13.9 | 12.7 | 123.5 |
| EMEGL | 414 | 38 | 4 | 0 | 5,259 | 954 | 220 | 1 | 5,641 | 801 | 12 | 2 |
| FDR(%) | 15.5 | 16.9 | 16.1 | – | 23.5 | 12.9 | 5.6 | 123.5 | 21.9 | 15.4 | 102.9 | 61.7 |
| SurvGL | 593 | 36 | 3 | 0 | 5,112 | 972 | 214 | 14 | 5,211 | 797 | 86 | 2 |
| FDR(%) | 10.9 | 17.8 | 21.4 | – | 24.2 | 12.7 | 5.8 | 8.8 | 23.8 | 15.5 | 14.4 | 61.7 |
| AvInfGL | 669 | 27 | 8 | 0 | 4,782 | 816 | 68 | 1 | 5,213 | 902 | 32 | 1 |
| FDR(%) | 10.1 | 23.7 | 8.1 | – | 25.8 | 15.1 | 18.2 | 123.5 | 23.7 | 13.7 | 38.6 | 123.5 |
Figure 2Increased power of WGS and meta-analysis of GWAS for internal infection as demonstrated by Manhattan plots for (a) transcriptomic genotyping-by-sequence (GBSt) at Wickliffe and (b) imputed whole-genome sequence (WGS) at Wickliffe and (c) multi-trait meta-analysis of GWAS for internal infection and survival at the two 2015 blackleg trials. The colour bar shows SNP density every 1Mbp. Figure produced in R3.6 using CMplot function (https://github.com/YinLiLin/R-CMplot).
Figure 3False discovery rate (at ) for GWAS using GBSt dosage, WGS dosage, WGS hard coded genotypes based on blackleg disease prone site (Wickliffe) and meta-analysis for blackleg disease traits (internal infection and survival). Figure produced in R3.6.
Figure 4A circular plot showing potential candidate genomic region associated with blackleg traits in Brassica napus L. across A and C sub-genome at thresholds shown as black, red, yellow and green lines, respectively. The top 50 significant SNPs across the regions are indicated in the circle. Figure produced in R3.6.
Meta-analysis for specific to blackleg traits and combined all-traits for the 2015 trials. FDR = False discovery rate.
| Meta-analysis for blackleg traits | Meta-analysis all-traits | |||||||
|---|---|---|---|---|---|---|---|---|
| No. of sig. SNPs and FDR at 4 p-values | No. of sig. SNPs and FDR at 4 p-values | |||||||
| p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | |
| No. of Sig SNP | 28,192 | 4,488 | 674 | 101 | 31,195 | 5,758 | 1,019 | 107 |
| FDR (%) | 4.4% | 2.8% | 1.8% | 1.2% | 3.9% | 2.1% | 1.2% | 1.2% |
Meta-analysis using a combined best linear unbiased estimates (BLUEs) from the Wickliffe and Green Lake 2015 trials.
| Traits | Combined site GWAS model | Meta-analysis to combine sites | ||||||
|---|---|---|---|---|---|---|---|---|
| No. of sig. SNPs and FDR at 4 p-values | No. of sig. SNPs and FDR at 4 p-values | |||||||
| p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | p < 10−3 | p < 10−4 | p < 10−5 | p < 10−6 | |
| EME | 9,210 | 1,279 | 20 | 3 | 11,917 | 1606 | 151 | 7 |
| FDR(%) | 13.4 | 9.6 | 61.7 | 41.2 | 10.4 | 7.7 | 8.2 | 17.6 |
| Surv | 8,480 | 1,205 | 60 | 2 | 9,982 | 1,343 | 264 | 12 |
| FDR(%) | 14.6 | 10.3 | 20.6 | 61.7 | 12.4 | 9.2 | 4.7 | 10.3 |
| AvInf | 10,010 | 1,376 | 90 | 2 | 13,122 | 1,486 | 103 | 9 |
| FDR(%) | 12.3 | 8.9 | 13.7 | 61.7 | 9.6 | 8.3 | 11.9 | 13.7 |
EME = emergence count, surv = survival rate, AvInf = Average internal infection, FDR = false discovery rate.
Figure 5Mean validation rates (%) of different validation strategies across four P-value thresholds (; ; ). Input information in Supplementary Tables S1–S6. Validation strategies are VS1) single-GBSt-to-single-GBSt: single-trait GWAS 2015 in dosage GBSt in discovery set and single-trait GWAS in GBSt dosage validation in 2016 and 2017 VS2) single-012-to-single-012: WGS single-trait GWAS 2015 in 012 (integer) in a discovery set and WGS single-trait GWAS in 012 (integer) validation in 2016 and 2017 VS3) single-to-single: single-trait dosage GWAS 2015 in discovery set and single-trait dosage GWAS validation in 2016 and 2017 VS4) meta-to-single: meta-analysis GWAS of blackleg traits in 2015 and validation in single trait GWAS in 2016 and 2017 VS5) CombModel-to-single: Combined model sites per traits GWAS in 2015 and validation in single trait GWAS in 2016 and 2017. VS6) meta-AvInt-to-singleAvInt: meta-analysis for AvInt GWAS in 2015 and validation in single-trait AvInt GWAS in 2016 and 2017. Figure produced in R3.6.